Faculty

Institution

Unit

Venue

Robert S. Benjamin

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Department Of Thoracic-Head And Neck Medical Oncology

Division Of Cancer Medicine

Departments Of Sarcoma Medical Oncology And Paediatrics

The University of Texas MD Anderson Cancer Center

Robert S. Benjamin is a High Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on surgical oncology, pathology, and radiation oncology, with a specific emphasis on soft tissue sarcomas, including undifferentiated pleomorphic sarcoma, synovial sarcoma, and malignant peripheral nerve sheath tumors. His recent work develops multiparametric-MRI-based radiomic models to predict treatment response in extremity sarcomas, replacing traditional RECIST criteria. He also investigates neoadjuvant immune-checkpoint blockade for retroperitoneal dedifferentiated liposarcoma and hypofractionated preoperative radiotherapy. His 2025 publications appear in venues such as Cancer Imaging, JCO Clinical Cancer Informatics, and Nature Cancer.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robert S. Benjamin

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology sarcoma radiation oncology medicine pharmacology cancer research cancer treatment surgical oncology cancer care pathology pharmacotherapy clinical research malignant disease medicinal research cancer management surgical pathology cancer biology metastasis cancer imaging applied pharmacology tumor biology pharmacological research jama oncology cancer cells hematology anti-cancer agents clinical trials thoracic oncology melanoma oncogenes tumoral pathology clinical pharmacology pharmacokinetics pharmaceutics metronomic chemotherapy medical mycology tumor targeting clinical mycology gastrointestinal oncology clinical radiation oncology hematological malignancies vascular biology cancer genomics radiation therapy brain tumor research phase ii study cardiovascular toxicity breast oncology therapeutic efficacy skin cancer tumor heterogeneity soft tissue sarcomas oncologic imaging cancer genetics pharmaceutical sciences imatinib mesylate gastrointestinal stromal tumors novel therapies gastrointestinal stromal tumor computed tomography pathologic lesions clinical evidence metastatic melanoma preoperative chemotherapy treatment and prevention ct scan cardiac pathologies combination chemotherapy soft tissue sarcoma soft-tissue sarcoma cancer patients malignant melanoma doxorubicin cardiotoxicity conservation surgery surgical resection neoadjuvant chemotherapy

Notable Scholarly Works

Notable Federal Grants

Collaborators

Building a Pre-Surgical Multiparametric-Mri-Based Morphologic, Qualitative, Semiquantitative, First and High-Order Radiomic Predictive Treatment Response Model for Undifferentiated Pleomorphic Sarcoma to Replace Recist. Cancer Imaging (2025)

undifferentiated pleomorphic sarcomacancer imagingoncologyclinical radiation oncologyradiation oncologysurgical oncologyradiation therapymedical imagingsarcomamri-guided radiation therapypre-surgical multiparametric-mri-based morphologicradiologysurgery

Nf1- and Non-Nf1–Associated Malignant Peripheral Nerve Sheath Tumors (Mpnst): The University of Texas MD Anderson (Mdacc) Experience.. Journal of Clinical Oncology (2025)

pathologytumoral pathologyneuropathologytumor innervationsurgical pathologyoncologymalignant diseasebrain tumor researchradiation oncologysarcomagliomastexas md andersonendocrine oncology

Novel Use and Value of Contrast-Enhanced Susceptibility-Weighted Imaging Morphologic and Radiomic Features in Predicting Extremity Soft Tissue Undifferentiated Pleomorphic Sarcoma Treatment Response. JCO Clinical Cancer Informatics (2025)

cancer imagingmusculoskeletal imagingradiomicsoncologynovel useoncologic imagingmedical imagingsarcomaradiologyradiomic featuresorthopaedic surgerynuclear medicine

Primary Intrathoracic Synovial Sarcoma: An Analysis of Outcomes of This Rare Disease. Cancers (2025)

pathologysarcomarare diseasesurgical pathology

Primary Synovial Sarcoma of the Abdomen and Pelvis. American Journal of Clinical Oncology (2025)

pathologytumoral pathologyhistopathologysurgical pathologymalignant diseasesarcomaprimary synovial sarcoma

1756P a Phase I/II Trial of Gemcitabine, Docetaxel, and Hydroxychloroquine in Advanced/Metastatic Osteosarcoma. Annals of Oncology (2024)

pharmacologycancer treatmentcancer researchoncologyradiation oncologymetastasispharmacotherapysarcomaanti-cancer agentsphase i/ii trialadvanced/metastatic osteosarcomacancer care

A Late-Arriving but Welcome Advance in Sarcoma Therapy. New England Journal of Medicine (2024)

cancer managementcancer treatmentmedicinecancer researchoncologymalignant diseasesarcoma therapysurgical oncologysarcomacancer care

A Randomized, Non-Comparative Phase 2 Study of Neoadjuvant Immune-Checkpoint Blockade in Retroperitoneal Dedifferentiated Liposarcoma and Extremity/Truncal Undifferentiated Pleomorphic Sarcoma. Nature Cancer (2024)

Christina L. RolandElise F. Nassif HaddadEmily Z. KeungWei-Lien WangAlexander J. LazarHeather LinManoj ChelvanambiEdwin R. ParraKhalida WaniB. Ashleigh GuadagnoloAndrew J. BishopElizabeth M. BurtonKelly K. HuntKeila E. TorresBarry W. FeigChristopher P. ScallyValerae O. LewisJustin E. BirdRavin RatanDejka AraujoM. Alexandra ZarzourShreyaskumar PatelRobert BenjaminAnthony P. ConleyJ. Andrew LivingstonVinod RaviHussein A. TawbiPatrick P. LinBryan S. MoonRobert L. SatcherBilal MujtabaRussell G. WittRaymond S. TraweekBrandon CopeRossana LazcanoChia-Chin WuXiao ZhouMohammad M. MohammadRandy A. ChuJianhua ZhangAshish DamaniaPranoti SahasrabhojaneTaylor TateKate CallahanSa NguyenDavis IngramRohini MoreyShadarra CrosbyGrace MathewSheila DuncanCibelle F. LimaJean-Yves BlayWolf Herman FridmanKenna ShawIgnacio WistubaAndrew FutrealNadim AjamiJennifer A. WargoNeeta Somaiah

cancer immunotherapypharmacologycancer biologycancer treatmentcancer cellstumor targetingcancer researchoncologysurgical oncologytherapeutic efficacysarcomacellular therapyimmunologyimmunotherapyradiologymedicinal researchimmune checkpoint inhibitorsneoadjuvant immune-checkpoint blockade

Clinical Characteristics and Outcomes of Adult Alveolar Rhabdomyosarcoma Patients on First-Line Systemic Therapies: A Single-Institution Cohort. Rare Tumors (2024)

cancer treatmentmedicinefirst-line systemic therapiesoncologyradiation oncologysurgical oncologysarcomasingle-institution cohortcancer careclinical characteristics

Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?. American Journal of Clinical Oncology (2024)

Riddhi R. PatelGeorge L. DelclosStacia M. DeSantisMichael B. CannellPhilip J. LupoAndrew J. BishopAlexander J. LazarPatrick P. LinRobert S. BenjaminShreyaskumar R. PatelJoseph LudwigVinod RaviJohn Andrew LivingstonNeeta SomaiahMaria Alejandra ZarzourAnthony P. ConleyDejka M. Araujo

cancer biologybiologycancer researchoncologyclinical researchtumor biologysynovial sarcoma

1
2
3
4
5
57
10 / page

Robert S. Benjamin

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Department Of Thoracic-Head And Neck Medical Oncology

Division Of Cancer Medicine

Departments Of Sarcoma Medical Oncology And Paediatrics

The University of Texas MD Anderson Cancer Center

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Robert S. Benjamin

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Nf1- and Non-Nf1–Associated Malignant Peripheral Nerve Sheath Tumors (Mpnst): The University of Texas MD Anderson (Mdacc) Experience.. Journal of Clinical Oncology (2025)

pathologytumoral pathologyneuropathologytumor innervationsurgical pathologyoncologymalignant diseasebrain tumor researchradiation oncologysarcomagliomastexas md andersonendocrine oncology

cancer imagingmusculoskeletal imagingradiomicsoncologynovel useoncologic imagingmedical imagingsarcomaradiologyradiomic featuresorthopaedic surgerynuclear medicine

Primary Intrathoracic Synovial Sarcoma: An Analysis of Outcomes of This Rare Disease. Cancers (2025)

pathologysarcomarare diseasesurgical pathology

Primary Synovial Sarcoma of the Abdomen and Pelvis. American Journal of Clinical Oncology (2025)

pathologytumoral pathologyhistopathologysurgical pathologymalignant diseasesarcomaprimary synovial sarcoma

1756P a Phase I/II Trial of Gemcitabine, Docetaxel, and Hydroxychloroquine in Advanced/Metastatic Osteosarcoma. Annals of Oncology (2024)

pharmacologycancer treatmentcancer researchoncologyradiation oncologymetastasispharmacotherapysarcomaanti-cancer agentsphase i/ii trialadvanced/metastatic osteosarcomacancer care

A Late-Arriving but Welcome Advance in Sarcoma Therapy. New England Journal of Medicine (2024)

cancer managementcancer treatmentmedicinecancer researchoncologymalignant diseasesarcoma therapysurgical oncologysarcomacancer care

Clinical Characteristics and Outcomes of Adult Alveolar Rhabdomyosarcoma Patients on First-Line Systemic Therapies: A Single-Institution Cohort. Rare Tumors (2024)

cancer treatmentmedicinefirst-line systemic therapiesoncologyradiation oncologysurgical oncologysarcomasingle-institution cohortcancer careclinical characteristics

Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?. American Journal of Clinical Oncology (2024)

cancer biologybiologycancer researchoncologyclinical researchtumor biologysynovial sarcoma

1
2
3
4
5
57
10 / page